SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-433742
Filing Date
2013-11-08
Accepted
2013-11-08 06:03:34
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d595997d10q.htm 10-Q 482157
2 EX-31.1 d595997dex311.htm EX-31.1 9301
3 EX-31.2 d595997dex312.htm EX-31.2 9302
4 EX-32.1 d595997dex321.htm EX-32.1 4963
  Complete submission text file 0001193125-13-433742.txt   5013277

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20130930.xml EX-101.INS 634756
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20130930.xsd EX-101.SCH 63115
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20130930_cal.xml EX-101.CAL 44882
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20130930_def.xml EX-101.DEF 255774
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20130930_lab.xml EX-101.LAB 454986
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20130930_pre.xml EX-101.PRE 341294
Mailing Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 131202432
SIC: 2834 Pharmaceutical Preparations